Effect of dysfunctional vascular endothelium on myocardial performance in isolated papillary muscles.

Vascular endothelium has been shown to modify the contractile characteristics of vascular smooth muscle, and endocardial endothelium has been shown to modify the contractile characteristics of adjacent myocardium. In this study, whether vascular endothelium also modifies the contractile characteristics of adjacent myocardium and whether these effects are additive to those of endocardial endothelium were investigated. Rabbit hearts (n = 54) were excised and mounted in a Langendorff preparation. Vascular reactivity was verified by acetylcholine infusion. One group of these hearts had Triton X-100 injected as a bolus into the coronaries to render the vascular endothelium dysfunctional. The other portion served as control hearts. Triton X-100 bolus injection resulted in little or no pathological changes on morphological examination; however, the vasodilatory response to acetylcholine in these hearts was abolished, suggesting vascular endothelial dysfunction. Vascular smooth muscle reactivity was verified in Triton X-100-injected hearts by nitroprusside infusion. In the control Langendorff-perfused hearts, there was little evidence of vascular endothelial dysfunction, with the coronary perfusion rate increasing from 8.9 +/- 0.4 to 11.0 +/- 0.3 ml/g per minute (p < 0.01) in response to acetylcholine. All hearts were then removed, and right ventricular papillary muscles were excised for myocardial mechanical studies. Control Langendorff-perfused hearts had myocardial mechanical characteristics similar to those of muscles from 18 other control hearts without Langendorff perfusion, indicating that the Langendorff perfusion itself had little effect on myocardial mechanics. The muscles from the Triton X-100-injected Langendorff hearts had marked changes: a shortening of twitch duration (363 +/- 16 versus 449 +/- 9 msec, p < 0.01) and decreases in total tension (2.2 +/- 0.2 versus 2.9 +/- 0.2 g/mm2, p < 0.01), dT/dt (9 +/- 1 versus 12 +/- 1 g/mm2 per second, p < 0.05), and maximum velocity of unloaded muscle shortening (Vmax) (0.89 +/- 0.06 versus 1.14 +/- 0.07 length at which maximum developed tension occurred [Lmax]/sec, p < 0.05). Endocardial endothelial removal of the papillary muscles in the two control groups (with and without Langendorff perfusion) by Triton X-100 caused the same changes in twitch characteristics as occurred in muscles from the Langendorff-perfused hearts injected with Triton X-100 but with intact endocardial endothelium, suggesting that vascular endothelial dysfunction had similar effects on contractile characteristics as endocardial endothelial removal.(ABSTRACT TRUNCATED AT 400 WORDS)

[1]  Robert M. Zwolack The endothelium: An introduction to current research , 1993 .

[2]  J. Morgan,et al.  Endocardial endothelium modulates myofilament Ca2+ responsiveness in aequorin-loaded ferret myocardium. , 1992, Circulation research.

[3]  A. Sharkey,et al.  Contractile proteins in myocardial cells are regulated by factor(s) released by blood vessels. , 1992, Circulation research.

[4]  P. Piper,et al.  Effect of removing the endothelium on the vascular responses induced by leukotrienes C4 and D4 in guinea-pig isolated heart. , 1992, European journal of pharmacology.

[5]  B. Krämer,et al.  Endothelins. Myocardial actions of a new class of cytokines. , 1992, Circulation.

[6]  J. Morgan,et al.  Endothelin 1 enhances myofilament Ca2+ responsiveness in aequorin-loaded ferret myocardium. , 1991, Circulation research.

[7]  J. Rouleau,et al.  Myocardial contractile actions of endothelin-1 in rat and rabbit papillary muscles. Role of endocardial endothelium. , 1991, Circulation research.

[8]  N. Sperelakis,et al.  cGMP inhibits the activity of single calcium channels in embryonic chick heart cells. , 1991, Circulation research.

[9]  K Lindpaintner,et al.  The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence. , 1991, Circulation research.

[10]  D. Brutsaert,et al.  Ventricular function. Is the total more than the sum of the parts? , 1991, Circulation.

[11]  D. Brutsaert,et al.  Role of endocardial endothelium in positive inotropic action of vasopressin. , 1990, The American journal of physiology.

[12]  B. Krämer,et al.  Endothelin enhances the contractile responsiveness of adult rat ventricular myocytes to calcium by a pertussis toxin-sensitive pathway. , 1990, The Journal of clinical investigation.

[13]  T. Tanaka,et al.  Release of norepinephrine from adrenergic nerve endings of blood vessels is modulated by endothelium-derived relaxing factor. , 1990, American journal of hypertension.

[14]  D. Brutsaert,et al.  Eosinophils from hypereosinophilic patients damage endocardium of isolated feline heart muscle preparations. , 1990, Circulation.

[15]  D. Stewart,et al.  Functional state of the endothelium determines the response to endothelin in the coronary circulation. , 1990, Cardiovascular research.

[16]  D. Brutsaert,et al.  Endocardium modulates myocardial inotropic response to 5-hydroxytryptamine. , 1989, The American journal of physiology.

[17]  M. Lazdunski,et al.  The inotropic effect of endothelin‐1 on rat atria involves hydrolysis of phosphatidylinositol , 1989, FEBS letters.

[18]  D. Brutsaert,et al.  Myocardial inotropic responses to aggregating platelets and modulation by the endocardium. , 1989, Circulation.

[19]  M. Bond,et al.  Endothelin is a positive inotropic agent in human and rat heart in vitro. , 1989, Biochemical and biophysical research communications.

[20]  J. Vane,et al.  Endothelin‐1 and Endothelin‐3 Release EDRF from Isolated Perfused Arterial Vessels of the Rat and Rabbit , 1989, Journal of cardiovascular pharmacology.

[21]  D. Brutsaert The endocardium. , 1989, Annual review of physiology.

[22]  K. Kusumoto,et al.  Positive Inotropic and Vasoconstrictive Effects of Endothelin‐1 in in vivo and in vitro Experiments: Characteristics and the Role of L‐Type Calcium Channels , 1989, Journal of cardiovascular pharmacology.

[23]  R. von Harsdorf,et al.  Endothelin has potent inotropic effects in rat atria. , 1988, European journal of pharmacology.

[24]  M. Yanagisawa,et al.  Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria. , 1988, The American journal of physiology.

[25]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[26]  D. Brutsaert,et al.  Effects of Damaging the Endocardial Surface on the Mechanical Performance of Isolated Cardiac Muscle , 1988, Circulation research.

[27]  J. R. Blinks,et al.  Actions of Sympathomimetic Amines on the Ca2+ Transients and Contractions of Rabbit Myocardium: Reciprocal Changes in Myofibrillar Responsiveness to Ca2+ Mediated Through α‐ and β‐Adrenoceptors , 1988, Circulation research.

[28]  D. Stewart,et al.  Balance between endothelium-mediated dilating and direct constricting actions of serotonin on resistance vessels in the isolated rabbit heart. , 1987, European journal of pharmacology.

[29]  V. Dzau Implications of local angiotensin production in cardiovascular physiology and pharmacology. , 1987, The American journal of cardiology.

[30]  R. Re The myocardial intracellular renin-angiotensin system. , 1987, The American journal of cardiology.

[31]  R. Furchgott,et al.  Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor. , 1986, The Journal of pharmacology and experimental therapeutics.

[32]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[33]  A. Helenius,et al.  Solubilization of membranes by detergents. , 1975, Biochimica et biophysica acta.

[34]  V A Claes,et al.  Effect of Calcium on Force‐Velocity‐Length Relations of Heart Muscle of the Cat , 1973, Circulation research.

[35]  P. Kadowitz,et al.  Influence of acetylcholine on contractile force and cyclic nucleotide levels in the isolated perfused rat heart. , 1973, The Journal of pharmacology and experimental therapeutics.